MHC associations of autoantibodies against recombinant Ro and La proteins in systemic lupus erythematosus
✍ Scribed by H. Ehrfeld; K. Hartung; M. Renz; R. Coldewey; H. Deicher; M. Fricke; J. R. Kalden; J. Lakomek; H. H. Peter; D. Schendel; H. P. Seelig
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 573 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
✦ Synopsis
Antibodies against recombinant 52 kD-Ro, recombinant 60 kD-Ro and recombinant La protein were determined by ELISA in over 300 central European patients with systemic lupus erythematosus (SLE). A strong association with HLA-DR3 was found for antibodies against 52 kD-Ro and La, but not for recombinant 60 kD-Ro antibodies in the absence of antibodies against 52 kD-Ro or La. Ro/La negative SLE patients still showed an increased frequency of HLA-DR3 as compared to healthy controls. These results indicated that the preferential formation of Ro and La antibodies was not due to an unspecific stimulatory effect of HLA-DR3 but that the antibody response to certain defined proteins (52 kD-Ro and La) was influenced by MHC genes in SLE. Furthermore, the association of SLE with HLA-DR3 was independent of the effects of DR3 on the formation of 52 kD-Ro and La antibodies.
📜 SIMILAR VOLUMES
Antibodies against Ro and La, including recombinant La and recombinant 60 kD-Ro, were determined by counter immunoelectrophoresis and ELISA in over 300 central European systemic lupus erythematosus (SLE) patients. The presence of both Ro and La antibodies was strongly associated with the MHC haploty
## Abstract ## Objective Interferon‐α (IFNα) is a primary pathogenic factor in systemic lupus erythematosus (SLE), and high IFNα levels may be associated with particular clinical manifestations. The prevalence of individual clinical and serologic features differs significantly by ancestry. This st